173 related articles for article (PubMed ID: 22896752)
21. Anti-idiotype antibody vaccine therapies of cancer.
Bhattacharya-Chatterjee M; Foon KA
Cancer Treat Res; 1998; 94():51-68. PubMed ID: 9587682
[No Abstract] [Full Text] [Related]
22. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
[TBL] [Abstract][Full Text] [Related]
23. A new twist on autologous cancer vaccines.
Emens LA
Cancer Biol Ther; 2003; 2(2):161-3. PubMed ID: 12750555
[No Abstract] [Full Text] [Related]
24. Application of monoclonal antibodies to tumor diagnosis and therapy.
Rosen ST; Winter JN; Epstein AL
Ann Clin Lab Sci; 1983; 13(3):173-84. PubMed ID: 6347022
[TBL] [Abstract][Full Text] [Related]
25. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
Jäger D; Jäger E; Bert F; Knuth A
Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
[No Abstract] [Full Text] [Related]
26. Serological identification of Tektin5 as a cancer/testis antigen and its immunogenicity.
Hanafusa T; Mohamed AE; Domae S; Nakayama E; Ono T
BMC Cancer; 2012 Nov; 12():520. PubMed ID: 23151147
[TBL] [Abstract][Full Text] [Related]
27. The Cancer Vaccine Collaborative: a new model of coordinated discovery.
O'Donnell-Tormey J; McDermott EA
Cancer Immun; 2012; 12():10. PubMed ID: 22896755
[No Abstract] [Full Text] [Related]
28. [Monoclonal antibodies and cancer].
López González JS; Selman Lama M
Salud Publica Mex; 1985; 27(3):213-34. PubMed ID: 2996157
[No Abstract] [Full Text] [Related]
29. Recombinant chimeric monoclonal antibodies.
Morrison SL; Schlom J
Important Adv Oncol; 1990; ():3-18. PubMed ID: 2182522
[No Abstract] [Full Text] [Related]
30. Antitumor vaccination using peptide based vaccines.
Eisenbach L; Bar-Haim E; El-Shami K
Immunol Lett; 2000 Sep; 74(1):27-34. PubMed ID: 10996624
[TBL] [Abstract][Full Text] [Related]
31. Cancer vaccines.
Liu MA
Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2823-6. PubMed ID: 21893546
[TBL] [Abstract][Full Text] [Related]
32. The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning.
Vaughan HA; St Clair F; Scanlan MJ; Chen YT; Maraskovsky E; Sizeland A; Old LJ; Cebon J
Cancer Immun; 2004 Jul; 4():5. PubMed ID: 15255672
[TBL] [Abstract][Full Text] [Related]
33. B7-1 gene-modified tumor cell vaccines.
Antonia SJ
Curr Opin Mol Ther; 1999 Feb; 1(1):50-6. PubMed ID: 11249684
[No Abstract] [Full Text] [Related]
34. The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy.
Cannon MJ; Block MS; Morehead LC; Knutson KL
Immunotherapy; 2019 Feb; 11(2):75-79. PubMed ID: 30730268
[No Abstract] [Full Text] [Related]
35. Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets.
Stanton SE; Gad E; Corulli LR; Lu H; Disis ML
Vaccine; 2019 Jun; 37(27):3552-3561. PubMed ID: 31126858
[TBL] [Abstract][Full Text] [Related]
36. Tumor cell vaccines.
Thompson PL; Dessureault S
Adv Exp Med Biol; 2007; 601():345-55. PubMed ID: 17713023
[TBL] [Abstract][Full Text] [Related]
37. The revival of cancer vaccines - The eminent need to activate humoral immunity.
Huijbers EJM; Griffioen AW
Hum Vaccin Immunother; 2017 May; 13(5):1112-1114. PubMed ID: 28118089
[TBL] [Abstract][Full Text] [Related]
38. Future directions in tumor immunotherapy: CTLA4 blockade.
Gulley JL; Dahut WL
Nat Clin Pract Oncol; 2007 Mar; 4(3):136-7. PubMed ID: 17327854
[No Abstract] [Full Text] [Related]
39. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy.
Scanlan MJ; Gure AO; Jungbluth AA; Old LJ; Chen YT
Immunol Rev; 2002 Oct; 188():22-32. PubMed ID: 12445278
[TBL] [Abstract][Full Text] [Related]
40. Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.
Ono T; Sato S; Kimura N; Tanaka M; Shibuya A; Old LJ; Nakayama E
Int J Cancer; 2000 Dec; 88(6):845-51. PubMed ID: 11093803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
